Review Examines Clinical Trials For Drug Development
Wang et al. (2026) publish in BIO Integration a review examining clinical trial phases I–IV, major challenges, and mitigation strategies. The article details ethical compliance, recruitment, diversity issues, and how AI, big‑data analytics, and digital health improve trial design and data quality. It also discusses impacts of gene therapy, immunotherapy, and the need for regulatory harmonization to support global drug development.
Scoring Rationale
Comprehensive, peer-reviewed review with broad industry relevance; novelty limited because it's synthesis rather than original findings.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problemsStep-by-step roadmaps from zero to job-ready — curated courses, salary data, and the exact learning order that gets you hired.
Sources
- Read OriginalReview examines clinical trial phases in drug developmentnews-medical.net
